Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 380 articles: HTML format

Single Articles

April 2024
1. BURCHILL LJ, Jain CC, Miranda WR
   Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
   J Am Coll Cardiol. 2024;83:1415-1417.
   PubMed    
   
   
   
2. MARTON A, Saffari SE, Rauh M, Sun RN, et al
   Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
   J Am Coll Cardiol. 2024;83:1386-1398.
   PubMed     Abstract available
   
   
   
3. NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al
   Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease.
   J Am Coll Cardiol. 2024;83:1403-1414.
   PubMed     Abstract available
   
   
   
4. ACHANTA A, Belak L, Ritchie CS, Januzzi JL, et al
   Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction.
   J Am Coll Cardiol. 2024;83:1348-1350.
   PubMed    
   
   
   
5. COSTANZO MR, Januzzi JL
   Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
   J Am Coll Cardiol. 2024;83:1307-1309.
   PubMed    
   
   
   
6. COX ZL, Collins SP, Hernandez GA, McRae AT 3rd, et al
   Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
   J Am Coll Cardiol. 2024;83:1295-1306.
   PubMed     Abstract available
   
   
   
7. COTTER G, Davison B, Chioncel O
   Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week.
   J Am Coll Cardiol. 2024;83:1243-1252.
   PubMed     Abstract available
   
   
   
8. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
   Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
   J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
   PubMed     Abstract available
   
   
   
9. CHATUR S, Neuen BL, Claggett BL, Beldhuis IE, et al
   Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.
   J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06691.
   PubMed     Abstract available
   
   
   March 2024
10. ATALLAH B, Ghalib HH
    Pooling the NT-proBNP Benefits of ARNI: Fret the Index Hospitalization No More.
    J Am Coll Cardiol. 2024;83:1133-1135.
    PubMed    
    
    
    
11. MORROW DA, Velazquez EJ, Desai AS, DeVore AD, et al
    Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
    J Am Coll Cardiol. 2024;83:1123-1132.
    PubMed     Abstract available
    
    
    
12. GONZALEZ-LOPEZ E, McPhail ED, Salas-Anton C, Dominguez F, et al
    Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1085-1099.
    PubMed     Abstract available
    
    
    
13. FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al
    Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478.
    PubMed     Abstract available
    
    
    
14. FUSTER V
    Editor-in-Chief's Top Picks From 2023.
    J Am Coll Cardiol. 2024;83:961-1026.
    PubMed     Abstract available
    
    
    
15. HAGE C, Sundstrom J, Lund LH
    More evidence that heart failure with normal EF distinct from heart failure is below normal EF.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990.
    PubMed    
    
    
    
16. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
    Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:932-950.
    PubMed     Abstract available
    
    
    
17. UDELL JA, Armstrong DWJ
    Targeting the Natriuretic Peptide System to Improve Outcomes: PARADISE Lost or Found.
    J Am Coll Cardiol. 2024;83:915-917.
    PubMed    
    
    
    
18. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
    Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
    J Am Coll Cardiol. 2024;83:904-914.
    PubMed     Abstract available
    
    
    
19. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2024 Mar 2:S0735-1097(23)08354.
    PubMed    
    
    
    February 2024
20. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    PubMed     Abstract available
    
    
    
21. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    PubMed     Abstract available
    
    
    
22. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    PubMed     Abstract available
    
    
    
23. FUDIM M, Butler J, Kittipibul V
    Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure.
    J Am Coll Cardiol. 2024;83:695-698.
    PubMed    
    
    
    
24. LINDENFELD J, Costanzo MR, Zile MR, Ducharme A, et al
    Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024;83:682-694.
    PubMed     Abstract available
    
    
    
25. SCHUMACHER KR, Vitale C
    It Is Shocking How Little We Have Talked About Cardiogenic Shock in Pediatrics.
    J Am Coll Cardiol. 2024;83:609-610.
    PubMed    
    
    
    
26. PURI K, Jentzer JC, Spinner JA, Hope KD, et al
    Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in Children.
    J Am Coll Cardiol. 2024;83:595-608.
    PubMed     Abstract available
    
    
    January 2024
27. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    PubMed     Abstract available
    
    
    
28. TROLLE LAGERROS Y, Grotta A, Freyland S, Grannas D, et al
    Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.
    J Am Coll Cardiol. 2024;83:417-426.
    PubMed     Abstract available
    
    
    
29. PACKER M
    Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:371-381.
    PubMed     Abstract available
    
    
    
30. ALOGNA A, Berboth L, Faragli A, Otvos J, et al
    Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.
    J Am Coll Cardiol. 2024;83:47-59.
    PubMed     Abstract available
    
    
    December 2023
31. LAMBERT G, Chemello K, Gallo A
    Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis.
    J Am Coll Cardiol. 2023;82:2292-2295.
    PubMed    
    
    
    November 2023
32. VADUGANATHAN M, Ostrominski JW
    Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the Ejection Fraction Divide.
    J Am Coll Cardiol. 2023;82:2097-2100.
    PubMed    
    
    
    
33. BUTLER J, Abildstrom SZ, Borlaug BA, Davies MJ, et al
    Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;82:2087-2096.
    PubMed     Abstract available
    
    
    
34. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
    Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2023;82:1989-2005.
    PubMed     Abstract available
    
    
    
35. BURGER PM, Visseren FLJ, Dorresteijn JAN
    Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e193.
    PubMed    
    
    
    
36. MORZE J, Rynkiewicz A
    C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e191-e192.
    PubMed    
    
    
    
37. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed     Abstract available
    
    
    
38. OUWERKERK W, Belo Pereira JP, Maasland T, Emmens JE, et al
    Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
    J Am Coll Cardiol. 2023;82:1921-1931.
    PubMed     Abstract available
    
    
    
39. COCA SG
    SGLT2i and Deterioration of Kidney Function in Heart Failure: Another Demonstration for Tolerance of "Hypercreatininemia".
    J Am Coll Cardiol. 2023;82:1864-1867.
    PubMed    
    
    
    
40. AGGARWAL R, Bhatt DL, Szarek M, Cannon CP, et al
    Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c.
    J Am Coll Cardiol. 2023;82:1842-1851.
    PubMed     Abstract available
    
    
    October 2023
41. REIL JC, Eitel I, Stiermaier T
    Reply: Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e145.
    PubMed    
    
    
    
42. KOMAMURA K
    Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e143.
    PubMed    
    
    
    
43. HONG KN, Eshraghian EA, Arad M, Argiro A, et al
    International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1628-1647.
    PubMed     Abstract available
    
    
    
44. ARNOLD SV, Goates S, Sorajja P, Adams DH, et al
    Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07743.
    PubMed     Abstract available
    
    
    
45. OHSHIRO Y
    Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;82:e133.
    PubMed    
    
    
    
46. TEDFORD RJ, Leacche M, Lorts A, Drakos SG, et al
    Durable Mechanical Circulatory Support: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;82:1464-1481.
    PubMed     Abstract available
    
    
    
47. GREGSON J, Stone GW, Bhatt DL, Packer M, et al
    Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1445-1463.
    PubMed     Abstract available
    
    
    September 2023
48. VERBRUGGE FH, Martens P, Mullens W
    Reply: Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e113.
    PubMed    
    
    
    
49. PAI RG
    Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e111.
    PubMed    
    
    
    
50. GOEL K, Lindenfeld J, Makkar R, Naik H, et al
    Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    J Am Coll Cardiol. 2023;82:1281-1297.
    PubMed     Abstract available
    
    
    August 2023
51. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    PubMed     Abstract available
    
    
    
52. CHATUR S, Vaduganathan M, Claggett BL, Mc Causland FR, et al
    Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m(2).
    J Am Coll Cardiol. 2023 Aug 23:S0735-1097(23)06532.
    PubMed     Abstract available
    
    
    
53. CHRISPIN J, Merchant FM, Lakdawala NK, Wu KC, et al
    Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:735-747.
    PubMed     Abstract available
    
    
    
54. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
    J Am Coll Cardiol. 2023;82:559-571.
    PubMed     Abstract available
    
    
    
55. JALLOH MB, Averbuch T, Kulkarni P, Granger CB, et al
    Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3.
    J Am Coll Cardiol. 2023;82:544-558.
    PubMed     Abstract available
    
    
    
56. PATOLIA H, Khan MS, Fonarow GC, Butler J, et al
    Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3.
    J Am Coll Cardiol. 2023;82:529-543.
    PubMed     Abstract available
    
    
    
57. GRAPSA J, Pinney SP
    Right Heart Dysfunction in HFpEF: More Complex and More Common Than We Thought.
    J Am Coll Cardiol. 2023;82:500-502.
    PubMed    
    
    
    
58. BUTLER J, Khan MS, Fonarow GC
    The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05963.
    PubMed    
    
    
    
59. KONDO T, Wang X, Yang M, Jhund PS, et al
    Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05964.
    PubMed     Abstract available
    
    
    
60. SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al
    First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With Advanced Heart Failure Undergoing VT Ablation.
    J Am Coll Cardiol. 2023;82:469-471.
    PubMed    
    
    
    
61. DEVORE AD, Allen LA
    A Global Challenge and a Global Opportunity for the Heart Failure Community.
    J Am Coll Cardiol. 2023;82:445-447.
    PubMed    
    
    
    
62. FOROUTAN F, Rayner DG, Ross HJ, Ehler T, et al
    Global Comparison of Readmission Rates for Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:430-444.
    PubMed     Abstract available
    
    
    
63. JIALAL I, Ebong IA
    The Evolving Role of C-Reactive Protein in Heart Failure: Implications for Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:427-429.
    PubMed    
    
    
    
64. BURGER PM, Koudstaal S, Mosterd A, Fiolet ATL, et al
    C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:414-426.
    PubMed     Abstract available
    
    
    
65. SAUER AJ, Hsia J
    Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With Reduced Ejection Fraction: Better Late Than Never?
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06074.
    PubMed    
    
    
    
66. MATSUMOTO S, Kondo T, Jhund PS, Campbell RT, et al
    Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06073.
    PubMed     Abstract available
    
    
    July 2023
67. VIJAYARAMAN P, Sharma PS, Cano O, Ponnusamy SS, et al
    Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy.
    J Am Coll Cardiol. 2023;82:228-241.
    PubMed     Abstract available
    
    
    
68. DOCHERTY KF, McDowell K, Welsh P, Osmanska J, et al
    Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:142-157.
    PubMed     Abstract available
    
    
    
69. ANKER MS, von Haehling S, Landmesser U
    Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.
    J Am Coll Cardiol. 2023;82:139-141.
    PubMed    
    
    
    
70. BAYES-GENIS A, de la Espriella R, Nunez J
    CA125 for Fluid Overload Monitoring: A New Life for an Old Tool.
    J Am Coll Cardiol. 2023;82:158-160.
    PubMed    
    
    
    
71. GRINSTEIN J, Belkin MN, Kalantari S, Bourque K, et al
    Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:70-81.
    PubMed     Abstract available
    
    
    June 2023
72. WIVIOTT SD, Berg DD
    SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death: Clarity and Consistency.
    J Am Coll Cardiol. 2023;81:2388-2390.
    PubMed    
    
    
    
73. USMAN MS, Siddiqi TJ, Anker SD, Bakris GL, et al
    Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
    J Am Coll Cardiol. 2023;81:2377-2387.
    PubMed     Abstract available
    
    
    
74. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;81:2299-2311.
    PubMed     Abstract available
    
    
    
75. STEVENSON LW, Ross HJ, Rathman LD, Boehmer JP, et al
    Remote Monitoring for Heart Failure Management at Home.
    J Am Coll Cardiol. 2023;81:2272-2291.
    PubMed     Abstract available
    
    
    
76. GOLDBERG LR
    Disrupting the Definition of Heart Failure: A Rose by Any Other Name.
    J Am Coll Cardiol. 2023;81:2243-2245.
    PubMed    
    
    
    
77. MOHEBI R, Wang D, Lau ES, Parekh JK, et al
    Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort.
    J Am Coll Cardiol. 2023;81:2231-2242.
    PubMed     Abstract available
    
    
    
78. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    PubMed     Abstract available
    
    
    
79. FONAROW GC, Greene SJ
    Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum.
    J Am Coll Cardiol. 2023;81:2145-2148.
    PubMed    
    
    
    
80. PAGNESI M, Metra M, Cohen-Solal A, Edwards C, et al
    Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2023;81:2131-2144.
    PubMed     Abstract available
    
    
    May 2023
81. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    PubMed     Abstract available
    
    
    
82. SCOTTI A, Coisne A, Granada JF, Driggin E, et al
    Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2023 May 27:S0735-1097(23)05584.
    PubMed     Abstract available
    
    
    
83. SUKUMAR S, Wasfy JH, Januzzi JL, Peppercorn J, et al
    Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2043-2055.
    PubMed     Abstract available
    
    
    
84. VERBRUGGE FH, Martens P, Dauw J, Nijst P, et al
    Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2023;81:2013-2024.
    PubMed     Abstract available
    
    
    
85. JOYCE E
    Natriuretic Response as a Biomarker of Decongestion in ADHF: Beyond Going With the Flow.
    J Am Coll Cardiol. 2023;81:2025-2027.
    PubMed    
    
    
    
86. KRISTENSEN SL, Jensen J, Schou M
    SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
    J Am Coll Cardiol. 2023;81:1915-1917.
    PubMed    
    
    
    
87. BUTLER J, Packer M, Siddiqi TJ, Bohm M, et al
    Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;81:1902-1914.
    PubMed     Abstract available
    
    
    
88. INCIARDI RM, Abanda M, Shah A, Cikes M, et al
    Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Trial.
    J Am Coll Cardiol. 2023 May 15:S0735-1097(23)05587.
    PubMed     Abstract available
    
    
    
89. MENTZ RJ, Ward JH, Hernandez AF, Lepage S, et al
    Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure.
    J Am Coll Cardiol. 2023 May 11:S0735-1097(23)05429.
    PubMed     Abstract available
    
    
    
90. KITTLESON MM, Panjrath GS, Amancherla K, Davis LL, et al
    2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2023;81:1835-1878.
    PubMed    
    
    
    
91. BORLAUG BA, Sharma K, Shah SJ, Ho JE, et al
    Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;81:1810-1834.
    PubMed     Abstract available
    
    
    
92. KODALI SK, Hahn RT, Davidson CJ, Narang A, et al
    1-Year Outcomes of Transcatheter Tricuspid Valve Repair.
    J Am Coll Cardiol. 2023;81:1766-1776.
    PubMed     Abstract available
    
    
    
93. VENTURA HO, Lavie CJ, Mehra MR
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: You Win Some, You Lose Some.
    J Am Coll Cardiol. 2023 May 3:S0735-1097(23)05526.
    PubMed    
    
    
    
94. MAMIC P, Snyder M, Tang WHW
    Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1729-1739.
    PubMed     Abstract available
    
    
    
95. FONAROW GC, Van Spall HGC, Januzzi JL Jr
    Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure.
    J Am Coll Cardiol. 2023;81:1694-1696.
    PubMed    
    
    
    April 2023
96. MIRANDA WR, Jain CC, Borlaug BA, Jaffe AS, et al
    Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan.
    J Am Coll Cardiol. 2023;81:1590-1600.
    PubMed     Abstract available
    
    
    
97. LENA A, Wilkenshoff U, Hadzibegovic S, Porthun J, et al
    Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
    J Am Coll Cardiol. 2023;81:1569-1586.
    PubMed     Abstract available
    
    
    
98. VERMA S, Bhatt DL, Dhingra NK, Steg PG, et al
    Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure.
    J Am Coll Cardiol. 2023;81:1546-1549.
    PubMed    
    
    
    
99. KHAN H, Kunutsor SK
    Nonsteroidal Anti-Inflammatory Drugs and Type 2 Diabetes: A Recipe for Heart Failure?
    J Am Coll Cardiol. 2023;81:1471-1473.
    PubMed    
    
    
    
100. HOLT A, Strange JE, Nouhravesh N, Nielsen SK, et al
     Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus.
     J Am Coll Cardiol. 2023;81:1459-1470.
     PubMed     Abstract available
     
     
     
101. COCA SG
     Learning to Embrace the Decline in eGFR After Initiation of Therapies for Heart Failure.
     J Am Coll Cardiol. 2023;81:1456-1458.
     PubMed    
     
     
     
102. AHMAD T, Desai NR, Clark KAA
     The EHR Has Exposed an Urgent Moral Imperative to Improve Heart Failure Care.
     J Am Coll Cardiol. 2023;81:1317-1319.
     PubMed    
     
     
     
103. YUN M, Bai Y, Nie B, Zhang X, et al
     Reply: Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
     J Am Coll Cardiol. 2023;81:e111.
     PubMed    
     
     
     
104. VALENZA G
     Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
     J Am Coll Cardiol. 2023;81:e109.
     PubMed    
     
     
     
105. CARNICELLI AP, Agarwal R, Tedford RJ, Ramaiah V, et al
     Critical Care Enrichment During Advanced Heart Failure Training.
     J Am Coll Cardiol. 2023;81:1296-1299.
     PubMed    
     
     
     
106. SORAJJA P, Cavalcante JL, Rodes-Cabau J
     Upstream Relief of Heart Failure Via Aortic Valve Replacement.
     J Am Coll Cardiol. 2023;81:1245-1247.
     PubMed    
     
     
     
107. KHAN KR, Khan OA, Chen C, Liu Y, et al
     Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction.
     J Am Coll Cardiol. 2023;81:1235-1244.
     PubMed     Abstract available
     
     
     March 2023
108. DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al
     Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.
     J Am Coll Cardiol. 2023;81:1151-1161.
     PubMed     Abstract available
     
     
     
109. LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al
     Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:1035-1045.
     PubMed     Abstract available
     
     
     
110. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
     Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
     J Am Coll Cardiol. 2023;81:964-975.
     PubMed     Abstract available
     
     
     
111. VADUGANATHAN M, Claggett BL, Jhund P, Miao ZM, et al
     Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2023;81:1004-1006.
     PubMed    
     
     
     
112. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
     Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
     J Am Coll Cardiol. 2023 Mar 14:S0735-1097(23)00368.
     PubMed     Abstract available
     
     
     
113. LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al
     Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
     J Am Coll Cardiol. 2023;81:e69.
     PubMed    
     
     
     
114. WU J, Liang J, Huang Y
     Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
     J Am Coll Cardiol. 2023;81:e67.
     PubMed    
     
     
     
115. MENASCHE P
     Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
     J Am Coll Cardiol. 2023;81:864-866.
     PubMed    
     
     
     
116. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
     Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
     J Am Coll Cardiol. 2023;81:849-863.
     PubMed     Abstract available
     
     
     February 2023
117. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
     Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
     J Am Coll Cardiol. 2023;81:708-710.
     PubMed    
     
     
     
118. BHATT AS, Varshney AS, Moscone A, Claggett BL, et al
     Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.
     J Am Coll Cardiol. 2023 Feb 21:S0735-1097(23)04471.
     PubMed     Abstract available
     
     
     
119. CHATUR S, Claggett BL, McCausland FR, Rouleau J, et al
     Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.
     J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00335.
     PubMed     Abstract available
     
     
     
120. MUKHOPADHYAY A, Reynolds HR, Phillips LM, Nagler AR, et al
     Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
     J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00329.
     PubMed     Abstract available
     
     
     
121. WEINTRAUB WS
     Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction.
     J Am Coll Cardiol. 2023;81:474-476.
     PubMed    
     
     
     
122. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
     Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
     J Am Coll Cardiol. 2023;81:460-473.
     PubMed     Abstract available
     
     
     January 2023
123. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
     Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;81:413-424.
     PubMed     Abstract available
     
     
     
124. PAGE RL 2ND
     The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation.
     J Am Coll Cardiol. 2023;81:332-335.
     PubMed    
     
     
     
125. KHAN MS, Shahid I, Anker SD, Fonarow GC, et al
     Albuminuria and Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:270-282.
     PubMed     Abstract available
     
     
     
126. MENTIAS A, Smedira NG, Krishnaswamy A, Reed GW, et al
     Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:105-115.
     PubMed     Abstract available
     
     
     
127. MARON MS, Masri A, Choudhury L, Olivotto I, et al
     Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:34-45.
     PubMed     Abstract available
     
     
     December 2022
128. LAI FTT, Chan EWW, Huang L, Cheung CL, et al
     Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.
     J Am Coll Cardiol. 2022;80:2255-2265.
     PubMed     Abstract available
     
     
     
129. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
     Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:2224-2238.
     PubMed     Abstract available
     
     
     
130. MA H, Wang X, Li X, Heianza Y, et al
     Adding Salt to Foods and Risk of Cardiovascular Disease.
     J Am Coll Cardiol. 2022;80:2157-2167.
     PubMed     Abstract available
     
     
     November 2022
131. CHANG YK, McClung JA, Allen LA, Philip J, et al
     Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach.
     J Am Coll Cardiol. 2022;80:e205-e206.
     PubMed    
     
     
     
132. AREVALO LORIDO JC, Salamanca Bautista P, Formiga F, Mendez Bailon M, et al
     Tackling Palliative Care in Advanced Heart Failure.
     J Am Coll Cardiol. 2022;80:e203-e204.
     PubMed    
     
     
     
133. RICKETTI DA, Krickus CL
     Strain on Palliative Care Services May Limit Resources for Advanced Heart Failure Patients.
     J Am Coll Cardiol. 2022;80:e201.
     PubMed    
     
     
     
134. PAHUJA M, Johnson A, Kabir R, Bhogal S, et al
     Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:2028-2049.
     PubMed     Abstract available
     
     
     
135. SCHINDLER TH, Valenta I, Dilsizian V
     Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure.
     J Am Coll Cardiol. 2022;80:1897-1899.
     PubMed    
     
     
     
136. BAI Y, Yun M, Nie B, Shan L, et al
     Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2022;80:1884-1896.
     PubMed     Abstract available
     
     
     
137. GIUSTINO G, Camaj A, Kapadia SR, Kar S, et al
     Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
     J Am Coll Cardiol. 2022;80:1857-1868.
     PubMed     Abstract available
     
     
     
138. NASSIF ME, Januzzi JL Jr
     Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?
     J Am Coll Cardiol. 2022;80:1785-1787.
     PubMed    
     
     
     
139. VADUGANATHAN M, Claggett BL, Jhund P, de Boer RA, et al
     Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure.
     J Am Coll Cardiol. 2022;80:1775-1784.
     PubMed     Abstract available
     
     
     
140. AL-MOHAMMAD A
     Circulating Plant-Based Omega-3 in Heart Failure: A Prognostic Marker or a Therapeutic Target?
     J Am Coll Cardiol. 2022;80:1759-1761.
     PubMed    
     
     
     
141. LAZARO I, Lupon J, Cediel G, Codina P, et al
     Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure.
     J Am Coll Cardiol. 2022;80:1751-1758.
     PubMed     Abstract available
     
     
     
142. ZANNAD F
     Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same Coin.
     J Am Coll Cardiol. 2022;80:1732-1734.
     PubMed    
     
     
     
143. SARRAJU A, Bakris G, Cannon CP, Cherney D, et al
     Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
     J Am Coll Cardiol. 2022;80:1721-1731.
     PubMed     Abstract available
     
     
     October 2022
144. SALAH HM, Goldberg LR, Molinger J, Felker GM, et al
     Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:1647-1659.
     PubMed     Abstract available
     
     
     
145. MOHEBI R, Liu Y, Pina IL, Prescott MF, et al
     Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2022;80:1529-1541.
     PubMed     Abstract available
     
     
     
146. WALSH MN
     Guideline-Directed Medical Therapy: Even a Little Is Better Than None.
     J Am Coll Cardiol. 2022;80:1542-1544.
     PubMed    
     
     
     
147. ASCHER SB, de Lemos JA, Lee M, Wu E, et al
     Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
     J Am Coll Cardiol. 2022;80:1516-1525.
     PubMed     Abstract available
     
     
     
148. JANUSZEWICZ A, Mulatero P, Dobrowolski P, Monticone S, et al
     Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:1480-1497.
     PubMed     Abstract available
     
     
     
149. SAVVATIS K, Vissing CR, Klouvi L, Florian A, et al
     Cardiac Outcomes in Adults With Mitochondrial Diseases.
     J Am Coll Cardiol. 2022;80:1421-1430.
     PubMed     Abstract available
     
     
     
150. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
     Natural History of MYH7-Related Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2022;80:1447-1461.
     PubMed     Abstract available
     
     
     
151. D'ALESSANDRO DA, Wolfe SB, Osho AA, Drezek K, et al
     Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death.
     J Am Coll Cardiol. 2022;80:1314-1326.
     PubMed     Abstract available
     
     
     September 2022
152. VIJAYARAMAN P, Batul SA
     Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
     J Am Coll Cardiol. 2022;80:1217-1219.
     PubMed    
     
     
     
153. WANG Y, Zhu H, Hou X, Wang Z, et al
     Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
     J Am Coll Cardiol. 2022;80:1205-1216.
     PubMed     Abstract available
     
     
     
154. KARAMLOU T, Devlin PJ, Hammoud MS
     Late Systemic Right Ventricle Failure: Moving Toward a Real-Time Prediction Tool.
     J Am Coll Cardiol. 2022;80:964-966.
     PubMed    
     
     
     
155. BROBERG CS, van Dissel A, Minnier J, Aboulhosn J, et al
     Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries.
     J Am Coll Cardiol. 2022;80:951-963.
     PubMed     Abstract available
     
     
     August 2022
156. IDRISS SF, Weiland MD
     Ventricular Pacing in Single Ventricle Circulation: Making the Best of a Difficult Situation.
     J Am Coll Cardiol. 2022;80:915-917.
     PubMed    
     
     
     
157. BUTT JH, Dewan P, Jhund PS, Anand IS, et al
     Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05596.
     PubMed     Abstract available
     
     
     
158. AHMAD T, Desai NR, Velazquez EJ
     SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure.
     J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05770.
     PubMed    
     
     
     
159. CUNNINGHAM JW, Vaduganathan M, Claggett BL, Kulac IJ, et al
     Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05673.
     PubMed     Abstract available
     
     
     
160. LA GERCHE A, Howden EJ, Haykowsky MJ, Lewis GD, et al
     Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome: JACC Focus Seminar 2/4.
     J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)05603.
     PubMed     Abstract available
     
     
     
161. LAU ES, Ho JE
     Reply: Previous Pregnancies and Heart Failure Prognosis.
     J Am Coll Cardiol. 2022;80:e61-e62.
     PubMed    
     
     
     
162. MARTINEZ-SELLES M
     Previous Pregnancies and Heart Failure Prognosis.
     J Am Coll Cardiol. 2022;80:e59.
     PubMed    
     
     
     
163. CORBALAN R, Acevedo M
     Glifozins and Atrial Fibrillation.
     J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
     PubMed    
     
     
     
164. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
     Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
     J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
     PubMed     Abstract available
     
     
     
165. HECKMAN GA, Rockwood K
     Frailty, Risk, and Heart Failure Care: Commission or Omission?
     J Am Coll Cardiol. 2022 Aug 12. pii: S0735-1097(22)05597.
     PubMed    
     
     
     
166. BOCCHI EA, Lima IGCV
     The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
     J Am Coll Cardiol. 2022;80:595-597.
     PubMed    
     
     
     
167. YE F, Wang X, Wu S, Ma S, et al
     Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
     J Am Coll Cardiol. 2022;80:584-594.
     PubMed     Abstract available
     
     
     
168. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
     Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
     J Am Coll Cardiol. 2022;80:565-578.
     PubMed     Abstract available
     
     
     
169. WILEY BM, Borlaug BA, Kane GC
     Lung Ultrasound in Heart Failure: Envisioning Handheld Ultrasound to Empower Nurses and Transform Health Care.
     J Am Coll Cardiol. 2022;80:524-526.
     PubMed    
     
     
     
170. ZISIS G, Yang Y, Huynh Q, Whitmore K, et al
     Nurse-Provided Lung and Inferior Vena Cava Assessment in Patients With Heart Failure.
     J Am Coll Cardiol. 2022;80:513-523.
     PubMed     Abstract available
     
     
     July 2022
171. BADRAN S, Lee S
     Even in Heart Failure, Integrating Palliative Care and Aggressive Medical Therapy Is a Thing.
     J Am Coll Cardiol. 2022;80:345-347.
     PubMed    
     
     
     
172. CHANG YK, Allen LA, McClung JA, Denvir MA, et al
     Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
     J Am Coll Cardiol. 2022;80:332-344.
     PubMed     Abstract available
     
     
     
173. KOCHAR A, Smilowitz NR, Hochman JS
     Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
     J Am Coll Cardiol. 2022;80:199-201.
     PubMed    
     
     
     
174. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
     Criteria for Defining Stages of Cardiogenic Shock Severity.
     J Am Coll Cardiol. 2022;80:185-198.
     PubMed     Abstract available
     
     
     
175. JANUZZI JL JR, Butler J
     The Importance of Worsening Heart Failure: Hiding in Plain Sight.
     J Am Coll Cardiol. 2022;80:123-125.
     PubMed    
     
     
     
176. AMBROSY AP, Parikh RV, Sung SH, Tan TC, et al
     Analysis of Worsening Heart Failure Events in an Integrated Health Care System.
     J Am Coll Cardiol. 2022;80:111-122.
     PubMed     Abstract available
     
     
     
177. SAUER AJ
     Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?
     J Am Coll Cardiol. 2022;80:19-21.
     PubMed    
     
     
     
178. BOHM M, Butler J, Filippatos G, Ferreira JP, et al
     Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.
     J Am Coll Cardiol. 2022;80:1-18.
     PubMed     Abstract available
     
     
     
179. FLORIDO R, Daya NR, Ndumele CE, Koton S, et al
     Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.
     J Am Coll Cardiol. 2022;80:22-32.
     PubMed     Abstract available
     
     
     June 2022
180. WASFY JH, O'Kelly AC
     Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage.
     J Am Coll Cardiol. 2022;79:2526-2528.
     PubMed    
     
     
     
181. FARIDI KF, Dayoub EJ, Ross JS, Dhruva SS, et al
     Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
     J Am Coll Cardiol. 2022;79:2516-2525.
     PubMed     Abstract available
     
     
     
182. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
     Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
     J Am Coll Cardiol. 2022;79:2471-2485.
     PubMed     Abstract available
     
     
     
183. BIONDI-ZOCCAI G, Peruzzi M, Frati G
     Is Smoking Cessation the Best Intervention Ever to Prevent Heart Failure?
     J Am Coll Cardiol. 2022;79:2306-2309.
     PubMed    
     
     
     
184. DING N, Shah AM, Blaha MJ, Chang PP, et al
     Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2022;79:2298-2305.
     PubMed     Abstract available
     
     
     
185. VERMA S, Pandey A, Bhatt DL
     Forecasting Heart Failure Risk in Diabetes.
     J Am Coll Cardiol. 2022;79:2294-2297.
     PubMed    
     
     
     
186. ECHOUFFO-TCHEUGUI JB, Ndumele CE, Zhang S, Florido R, et al
     Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.
     J Am Coll Cardiol. 2022;79:2285-2293.
     PubMed     Abstract available
     
     
     
187. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
     Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:2349-2366.
     PubMed     Abstract available
     
     
     May 2022
188. SCHOCKEN DD
     Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?
     J Am Coll Cardiol. 2022;79:2034-2036.
     PubMed    
     
     
     
189. BUGIARDINI R, Yoon J, Mendieta G, Kedev S, et al
     Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.
     J Am Coll Cardiol. 2022;79:2021-2033.
     PubMed     Abstract available
     
     
     
190. UDELL JA, Jones WS, Petrie MC, Harrington J, et al
     Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:2058-2068.
     PubMed     Abstract available
     
     
     
191. NORRISH G, Cleary A, Field E, Cervi E, et al
     Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1986-1997.
     PubMed     Abstract available
     
     
     
192. DALY KP, Zuckerman WA
     The Burden of Pediatric Heart Failure That Lies Just Under the Surface.
     J Am Coll Cardiol. 2022;79:1929-1931.
     PubMed    
     
     
     
193. AMDANI S, Marino BS, Rossano J, Lopez R, et al
     Burden of Pediatric Heart Failure in the United States.
     J Am Coll Cardiol. 2022;79:1917-1928.
     PubMed     Abstract available
     
     
     
194. FUDIM M, Kaye DM, Borlaug BA, Shah SJ, et al
     Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:1858-1869.
     PubMed     Abstract available
     
     
     April 2022
195. DRIGGIN E, Cohen LP, Gallagher D, Karmally W, et al
     Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:1623-1635.
     PubMed     Abstract available
     
     
     
196. DEFILIPPIS EM
     Infertility: A Fertile Ground for Heart Failure?
     J Am Coll Cardiol. 2022;79:1604-1605.
     PubMed    
     
     
     
197. LAU ES, Wang D, Roberts M, Taylor CN, et al
     Infertility and Risk of Heart Failure in the Women's Health Initiative.
     J Am Coll Cardiol. 2022;79:1594-1603.
     PubMed     Abstract available
     
     
     
198. NEGISHI K, Pathan F
     Novel Left Atrial Markers for Risk Stratification of Heart Failure: Ready for Prime Time?
     J Am Coll Cardiol. 2022;79:1562-1564.
     PubMed    
     
     
     
199. INCIARDI RM, Claggett B, Minamisawa M, Shin SH, et al
     Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
     J Am Coll Cardiol. 2022;79:1549-1561.
     PubMed     Abstract available
     
     
     
200. KHAN SS, Beach LB, Yancy CW
     Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7.
     J Am Coll Cardiol. 2022;79:1530-1541.
     PubMed     Abstract available
     
     
     
201. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
     Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
     J Am Coll Cardiol. 2022;79:1441-1453.
     PubMed     Abstract available
     
     
     
202. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
     Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
     J Am Coll Cardiol. 2022;79:1429-1437.
     PubMed     Abstract available
     
     
     
203. LINDLEY KJ, Williams D, Davila-Roman VG
     Reply: When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
     J Am Coll Cardiol. 2022;79:e243.
     PubMed    
     
     
     
204. SCIATTI E, Orabona R
     When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
     J Am Coll Cardiol. 2022;79:e241.
     PubMed    
     
     
     
205. KRIEGER EV, Kim YY
     Lumping vs Splitting in Adult Congenital Heart Disease Research.
     J Am Coll Cardiol. 2022;79:1366-1368.
     PubMed    
     
     
     March 2022
206. FERREIRA JP, Butler J, Zannad F, Filippatos G, et al
     Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022;79:1129-1137.
     PubMed     Abstract available
     
     
     
207. VAN SPALL HGC, Fonarow GC, Mamas MA
     Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
     J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(22)04564.
     PubMed    
     
     
     
208. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
     2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08394.
     PubMed     Abstract available
     
     
     
209. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
     2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08395.
     PubMed     Abstract available
     
     
     
210. VARSHNEY AS, DeFilippis EM, Cowger JA, Netuka I, et al
     Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.
     J Am Coll Cardiol. 2022;79:1092-1107.
     PubMed     Abstract available
     
     
     
211. GHAZI L, Yamamoto Y, Riello RJ, Coronel-Moreno C, et al
     Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
     J Am Coll Cardiol. 2022 Mar 19. pii: S0735-1097(22)04489.
     PubMed     Abstract available
     
     
     
212. PALAU P, Seller J, Dominguez E, Bayes-Genis A, et al
     Reply: Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022;79:e197-e198.
     PubMed    
     
     
     
213. FAUCHIER L, Bodin A, Bisson A
     Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022;79:e195.
     PubMed    
     
     
     
214. JANUZZI JL JR, Ohman EM
     Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.
     J Am Coll Cardiol. 2022;79:861-863.
     PubMed    
     
     
     
215. ZHENG J, Heidenreich PA, Kohsaka S, Fearon WF, et al
     Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
     J Am Coll Cardiol. 2022;79:849-860.
     PubMed     Abstract available
     
     
     
216. TOPKARA VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, et al
     Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.
     J Am Coll Cardiol. 2022;79:900-913.
     PubMed     Abstract available
     
     
     
217. JEFFERIES JL, Saffitz JE
     Autophagy and Reverse Remodeling: A New Biomarker in Heart Failure?
     J Am Coll Cardiol. 2022;79:802-804.
     PubMed    
     
     
     
218. KANAMORI H, Yoshida A, Naruse G, Endo S, et al
     Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:789-801.
     PubMed     Abstract available
     
     
     February 2022
219. FIUZAT M, Hamo CE, Butler J, Abraham WT, et al
     Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:504-510.
     PubMed     Abstract available
     
     
     
220. VADUGANATHAN M, Sattar N, Xu J, Butler J, et al
     Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
     J Am Coll Cardiol. 2022;79:432-444.
     PubMed     Abstract available
     
     
     
221. FONTES JD, Massera D
     The Path to Better Understanding Heart Failure Epidemiology.
     J Am Coll Cardiol. 2022;79:369-371.
     PubMed    
     
     
     
222. CHANDRA A, Skali H, Claggett B, Solomon SD, et al
     Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.
     J Am Coll Cardiol. 2022;79:355-368.
     PubMed     Abstract available
     
     
     
223. MASINI G, Graham FJ, Pellicori P, Cleland JGF, et al
     Criteria for Iron Deficiency in Patients With Heart Failure.
     J Am Coll Cardiol. 2022;79:341-351.
     PubMed     Abstract available
     
     
     
224. COSTANZO MR, Januzzi JL Jr
     21st Century CE: The New Iron Age?
     J Am Coll Cardiol. 2022;79:352-354.
     PubMed    
     
     
     January 2022
225. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
     Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
     J Am Coll Cardiol. 2022;79:267-279.
     PubMed     Abstract available
     
     
     
226. WALSH MN
     Change in Lifetime Risk of Heart Failure: Applicable to All?
     J Am Coll Cardiol. 2022;79:264-266.
     PubMed    
     
     
     
227. VASAN RS, Enserro DM, Beiser AS, Xanthakis V, et al
     Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
     J Am Coll Cardiol. 2022;79:250-263.
     PubMed     Abstract available
     
     
     
228. MANTOVANI A, Byrne CD, Benfari G, Bonapace S, et al
     Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:180-191.
     PubMed     Abstract available
     
     
     
229. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
     Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:166-179.
     PubMed     Abstract available
     
     
     
230. BERRY C, Ibanez B
     Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:49-51.
     PubMed    
     
     
     December 2021
231. EMERSON D, Chikwe J, Catarino P, Kobashigawa J, et al
     Reply: Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
     J Am Coll Cardiol. 2021;78:e323.
     PubMed    
     
     
     
232. RODENAS-ALESINA E, Billia F, Rao V, Ross HJ, et al
     Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
     J Am Coll Cardiol. 2021;78:e321.
     PubMed    
     
     
     
233. PINA IL, Jimenez S, Lewis EF, Morris AA, et al
     Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.
     J Am Coll Cardiol. 2021;78:2589-2598.
     PubMed     Abstract available
     
     
     
234. RAME JE, Pagani FD, Kiernan MS, Oliveira GH, et al
     Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.
     J Am Coll Cardiol. 2021;78:2294-2308.
     PubMed     Abstract available
     
     
     
235. HONIGBERG MC
     Understanding Heart Failure in Women With Preeclampsia: A Call for Prevention.
     J Am Coll Cardiol. 2021;78:2291-2293.
     PubMed    
     
     
     
236. WILLIAMS D, Stout MJ, Rosenbloom JI, Olsen MA, et al
     Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2281-2290.
     PubMed     Abstract available
     
     
     November 2021
237. GANDHI PU, Windish DM
     Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
     J Am Coll Cardiol. 2021;78:2265-2266.
     PubMed    
     
     
     
238. PALAU P, Seller J, Dominguez E, Sastre C, et al
     Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2042-2056.
     PubMed     Abstract available
     
     
     
239. GUAZZI M
     The Link Between Heart Rate, Exercise, and beta-Blocker in HFpEF: Time to Untie the Knot.
     J Am Coll Cardiol. 2021;78:2057-2059.
     PubMed    
     
     
     
240. ZHANG J, Bolli R, Garry DJ, Marban E, et al
     Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:2092-2105.
     PubMed     Abstract available
     
     
     
241. GOTTLIEB SH
     Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
     J Am Coll Cardiol. 2021;78:2013-2016.
     PubMed    
     
     
     
242. RAO VN, Murray E, Butler J, Cooper LB, et al
     In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2004-2012.
     PubMed     Abstract available
     
     
     
243. KINDEL SJ
     Pediatric Data for Pediatric Heart Failure: Stepping Out on Our Own.
     J Am Coll Cardiol. 2021;78:1901-1903.
     PubMed    
     
     
     
244. PALM J, Holdenrieder S, Hoffmann G, Horer J, et al
     Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.
     J Am Coll Cardiol. 2021;78:1890-1900.
     PubMed     Abstract available
     
     
     
245. AMBARDEKAR AV, Stratton MS, Dobrinskikh E, Hunter KS, et al
     Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.
     J Am Coll Cardiol. 2021;78:1782-1795.
     PubMed     Abstract available
     
     
     
246. WANNER PM, Wulff DU, Djurdjevic M, Korte W, et al
     Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
     J Am Coll Cardiol. 2021;78:1753-1764.
     PubMed     Abstract available
     
     
     October 2021
247. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
     Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;78:1751-1752.
     PubMed    
     
     
     
248. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
     Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:1682-1699.
     PubMed     Abstract available
     
     
     
249. ITOGA NK, Tawfik DS, Montez-Rath ME, Chang TI, et al
     Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
     J Am Coll Cardiol. 2021;78:1671-1678.
     PubMed     Abstract available
     
     
     
250. RANGASWAMI J, Lo KB, Vaduganathan M, Mathew RO, et al
     Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.
     J Am Coll Cardiol. 2021;78:1669-1670.
     PubMed    
     
     
     
251. SEGAR MW, Khan MS, Patel KV, Butler J, et al
     Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
     J Am Coll Cardiol. 2021;78:1587-1598.
     PubMed     Abstract available
     
     
     
252. KENCHAIAH S, Budoff MJ, Ding J, Carr JJ, et al
     Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
     J Am Coll Cardiol. 2021;78:e113-e115.
     PubMed    
     
     
     
253. BONAPACE S, Molon G, Marinelli A, Lanzoni L, et al
     Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
     J Am Coll Cardiol. 2021;78:e111.
     PubMed    
     
     
     
254. LEE HH, Lee H, Cho SMJ, Kim DW, et al
     On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
     J Am Coll Cardiol. 2021;78:1485-1495.
     PubMed     Abstract available
     
     
     September 2021
255. BOHM M, Anker SD, Butler J, Filippatos G, et al
     Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.
     J Am Coll Cardiol. 2021;78:1337-1348.
     PubMed     Abstract available
     
     
     
256. CUNNINGHAM JW, Myhre PL
     NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.
     J Am Coll Cardiol. 2021;78:1333-1336.
     PubMed    
     
     
     
257. JANUZZI JL JR, Zannad F, Anker SD, Butler J, et al
     Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
     J Am Coll Cardiol. 2021;78:1321-1332.
     PubMed     Abstract available
     
     
     
258. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
     Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:1166-1187.
     PubMed     Abstract available
     
     
     August 2021
259. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
     Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:931-956.
     PubMed     Abstract available
     
     
     
260. PAGANI FD
     Is Durable Left Ventricular Assist Device Therapy a Viable Option for the Elderly?
     J Am Coll Cardiol. 2021;78:895-897.
     PubMed    
     
     
     
261. EMERSON D, Chikwe J, Catarino P, Hassanein M, et al
     Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.
     J Am Coll Cardiol. 2021;78:883-894.
     PubMed     Abstract available
     
     
     
262. HERSBERGER L, Stanga Z, Schuetz P
     Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
     J Am Coll Cardiol. 2021;78:856-857.
     PubMed    
     
     
     
263. IKOMA T, Saito H, Oka T, Maekawa Y, et al
     The Importance of Objective Nutritional Indexes in Heart Failure Patients.
     J Am Coll Cardiol. 2021;78:855-856.
     PubMed    
     
     
     
264. DROZD M, Cubbon RM
     Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
     J Am Coll Cardiol. 2021;78:760.
     PubMed    
     
     
     
265. SHEN L, Jhund PS, McMurray JJV
     Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
     J Am Coll Cardiol. 2021;78:760-761.
     PubMed    
     
     
     
266. MEWTON N, Baudry G, Sebbag L
     Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
     J Am Coll Cardiol. 2021;78:759.
     PubMed    
     
     
     
267. LEWANDOWSKI AJ, Raman B, Bertagnolli M, Mohamed A, et al
     Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood.
     J Am Coll Cardiol. 2021;78:683-692.
     PubMed     Abstract available
     
     
     
268. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
     Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
     J Am Coll Cardiol. 2021;78:643-662.
     PubMed     Abstract available
     
     
     
269. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
     Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
     J Am Coll Cardiol. 2021;78:637-638.
     PubMed    
     
     
     
270. DEL BUONO MG, Van Tassell BW, Abbate A
     Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
     J Am Coll Cardiol. 2021;78:637.
     PubMed    
     
     
     
271. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
     Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
     J Am Coll Cardiol. 2021;78:543-544.
     PubMed    
     
     
     
272. SHCHENDRYGINA A, Mewton N, Meznar AZ
     Advanced Heart Failure and Angiotensin System Fascinating Complexities.
     J Am Coll Cardiol. 2021;78:541-542.
     PubMed    
     
     
     
273. LI L, Wang J, Zhao G, Topaz S, et al
     Percutaneous DLC-Based Total Cavopulmonary Assist Achieves 96-Hour Survival in Lethal Cavopulmonary Failure Sheep.
     J Am Coll Cardiol. 2021;78:538-540.
     PubMed    
     
     
     July 2021
274. ROSSIGNOL P, Pitt B
     Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
     J Am Coll Cardiol. 2021;78:344-347.
     PubMed    
     
     
     
275. ITKIN M, Rockson SG, Burkhoff D
     Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:278-290.
     PubMed     Abstract available
     
     
     
276. AMUNDSEN BH
     Atrial Strain: A Piece of the HFpEF Puzzle Found, But Not Yet in Place.
     J Am Coll Cardiol. 2021;78:258-259.
     PubMed    
     
     
     
277. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
     Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.
     J Am Coll Cardiol. 2021;78:97-108.
     PubMed     Abstract available
     
     
     
278. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
     Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:66-76.
     PubMed     Abstract available
     
     
     
279. FUSTER JJ
     Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
     J Am Coll Cardiol. 2021;78:53-55.
     PubMed    
     
     
     
280. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
     Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
     J Am Coll Cardiol. 2021;78:42-52.
     PubMed     Abstract available
     
     
     
281. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
     Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
     J Am Coll Cardiol. 2021;78:14-23.
     PubMed     Abstract available
     
     
     June 2021
282. LAM CSP, Solomon SD
     Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:3217-3225.
     PubMed     Abstract available
     
     
     
283. CONDORELLI G, Ferrante G
     MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
     J Am Coll Cardiol. 2021;77:2936-2938.
     PubMed    
     
     
     
284. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
     AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
     J Am Coll Cardiol. 2021;77:2923-2935.
     PubMed     Abstract available
     
     
     
285. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
     Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;77:2796-2803.
     PubMed     Abstract available
     
     
     
286. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
     Pericardial Fat and the Risk of Heart Failure.
     J Am Coll Cardiol. 2021;77:2638-2652.
     PubMed     Abstract available
     
     
     May 2021
287. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
     Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2432-2447.
     PubMed     Abstract available
     
     
     
288. GOTTLIEB SH
     Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
     J Am Coll Cardiol. 2021;77:2320-2322.
     PubMed    
     
     
     
289. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
     Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
     J Am Coll Cardiol. 2021;77:2307-2319.
     PubMed     Abstract available
     
     
     
290. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
     New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
     J Am Coll Cardiol. 2021;77:2260-2262.
     PubMed    
     
     
     
291. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
     Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
     PubMed     Abstract available
     
     
     April 2021
292. MANCINI D, Gibson GT
     Impact of Pneumonia in Heart Failure Patients.
     J Am Coll Cardiol. 2021;77:1974-1976.
     PubMed    
     
     
     
293. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
     Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1961-1973.
     PubMed     Abstract available
     
     
     
294. HONKA H, Solis-Herrera C, Triplitt C, Norton L, et al
     Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2022-2039.
     PubMed     Abstract available
     
     
     
295. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
     Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1952-1953.
     PubMed    
     
     
     
296. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
     Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
     J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
     PubMed    
     
     
     
297. RAUH MJ
     Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
     J Am Coll Cardiol. 2021;77:1760-1762.
     PubMed    
     
     
     
298. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
     Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1747-1759.
     PubMed     Abstract available
     
     
     
299. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
     Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
     J Am Coll Cardiol. 2021;77:1731-1743.
     PubMed     Abstract available
     
     
     
300. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
     Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
     J Am Coll Cardiol. 2021;77:1717-1727.
     PubMed     Abstract available
     
     
     March 2021
301. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
     Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
     J Am Coll Cardiol. 2021;77:1454-1469.
     PubMed     Abstract available
     
     
     
302. GREENE SJ, Khan MS
     Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
     J Am Coll Cardiol. 2021;77:1408-1411.
     PubMed    
     
     
     
303. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
     Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
     J Am Coll Cardiol. 2021;77:1397-1407.
     PubMed     Abstract available
     
     
     
304. KOSIBOROD MN, Vaduganathan M
     SGLT-2 Inhibitors in Heart Failure: Volume or Value?
     J Am Coll Cardiol. 2021;77:1393-1396.
     PubMed    
     
     
     
305. PACKER M, Anker SD, Butler J, Filippatos G, et al
     Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
     J Am Coll Cardiol. 2021;77:1381-1392.
     PubMed     Abstract available
     
     
     
306. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
     TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
     J Am Coll Cardiol. 2021;77:1481-1483.
     PubMed    
     
     
     
307. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
     SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
     J Am Coll Cardiol. 2021;77:1375-1377.
     PubMed    
     
     
     
308. MCCULLOUGH PA, Rahimi G, Tecson KM
     Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1222-1224.
     PubMed    
     
     
     
309. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
     Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
     J Am Coll Cardiol. 2021;77:1211-1221.
     PubMed     Abstract available
     
     
     
310. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
     Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:1243-1256.
     PubMed     Abstract available
     
     
     
311. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
     3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1029-1040.
     PubMed     Abstract available
     
     
     
312. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
     Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
     J Am Coll Cardiol. 2021;77:1044-1052.
     PubMed     Abstract available
     
     
     February 2021
313. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
     Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
     J Am Coll Cardiol. 2021;77:1023-1025.
     PubMed    
     
     
     
314. FELKER GM, Greene SJ
     Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
     J Am Coll Cardiol. 2021;77:709-712.
     PubMed    
     
     
     
315. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
     Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:695-708.
     PubMed     Abstract available
     
     
     
316. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
     Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2021;77:713-724.
     PubMed     Abstract available
     
     
     
317. GOODLIN SJ
     RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
     J Am Coll Cardiol. 2021;77:504-505.
     PubMed    
     
     
     
318. CHUZI S, Khan SS, Pak ES
     Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
     J Am Coll Cardiol. 2021;77:501-505.
     PubMed    
     
     
     
319. FRISK M, Le C, Shen X, Roe AT, et al
     Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:405-419.
     PubMed     Abstract available
     
     
     
320. HULOT JS, Livrozet M
     HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
     J Am Coll Cardiol. 2021;77:420-422.
     PubMed    
     
     
     January 2021
321. GOLDBERG LR
     The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
     J Am Coll Cardiol. 2021;77:256-258.
     PubMed    
     
     
     
322. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
     Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
     J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
     PubMed    
     
     
     
323. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
     2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
     J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
     PubMed    
     
     
     December 2020
324. PAGANI FD
     Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
     J Am Coll Cardiol. 2020;76:2965-2967.
     PubMed    
     
     
     
325. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
     Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
     J Am Coll Cardiol. 2020;76:2940-2951.
     PubMed     Abstract available
     
     
     
326. ALAHMAD B, Khraishah H
     Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
     J Am Coll Cardiol. 2020;76:2875-2877.
     PubMed    
     
     
     
327. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
     Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
     J Am Coll Cardiol. 2020;76:2862-2874.
     PubMed     Abstract available
     
     
     
328. GUPTA DK, Crescenzi R, Aday AW
     Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2830-2833.
     PubMed    
     
     
     
329. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
     Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2817-2829.
     PubMed     Abstract available
     
     
     
330. JANUZZI JL JR, Ibrahim NE
     Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
     J Am Coll Cardiol. 2020;76:2752-2754.
     PubMed    
     
     
     
331. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
     Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2740-2751.
     PubMed     Abstract available
     
     
     
332. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
     Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:2671-2681.
     PubMed     Abstract available
     
     
     
333. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
     Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:2595-2606.
     PubMed     Abstract available
     
     
     November 2020
334. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
     2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
     J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
     PubMed    
     
     
     
335. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
     Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
     J Am Coll Cardiol. 2020;76:2334-2348.
     PubMed     Abstract available
     
     
     
336. FASELIS C, Fonarow GC, Ahmed A
     Reply: Diuretics After Heart Failure Hospitalization, Not for All!
     J Am Coll Cardiol. 2020;76:2418-2420.
     PubMed    
     
     
     
337. DAUW J, Mullens W
     Diuretics After Heart Failure Hospitalization, Not for All!
     J Am Coll Cardiol. 2020;76:2418.
     PubMed    
     
     
     
338. PANJRATH GS, Krepp J
     COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
     J Am Coll Cardiol. 2020;76:2349-2351.
     PubMed    
     
     
     
339. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
     Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
     J Am Coll Cardiol. 2020;76:2417-2418.
     PubMed    
     
     
     
340. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
     Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
     J Am Coll Cardiol. 2020;76:2416-2417.
     PubMed    
     
     
     
341. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
     Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
     PubMed     Abstract available
     
     
     
342. VELAZQUEZ EJ, Reinhardt SW
     Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
     J Am Coll Cardiol. 2020;76:2086-2088.
     PubMed    
     
     
     October 2020
343. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
     Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
     J Am Coll Cardiol. 2020;76:2040-2041.
     PubMed    
     
     
     
344. FUDIM M, Soloveva A
     Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
     J Am Coll Cardiol. 2020;76:2038-2039.
     PubMed    
     
     
     
345. LIU PP, Al-Khalaf M, Blet A
     Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
     J Am Coll Cardiol. 2020;76:1995-1998.
     PubMed    
     
     
     
346. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
     Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2020;76:1982-1994.
     PubMed     Abstract available
     
     
     
347. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
     Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
     J Am Coll Cardiol. 2020;76:1919-1930.
     PubMed     Abstract available
     
     
     
348. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
     2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
     J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
     PubMed    
     
     
     
349. KITTLESON MM
     The Trials of Women in Cardiology.
     J Am Coll Cardiol. 2020;76:1931-1933.
     PubMed    
     
     
     
350. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
     Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:1795-1807.
     PubMed     Abstract available
     
     
     
351. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
     Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
     J Am Coll Cardiol. 2020;76:1717-1718.
     PubMed    
     
     
     
352. MEWTON N, Sebbag L, Bochaton T
     Other Things Behind the Low Rate of Heart Failure Trial Publication.
     J Am Coll Cardiol. 2020;76:1716-1717.
     PubMed    
     
     
     
353. MEHMOOD M
     Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
     J Am Coll Cardiol. 2020;76:1715-1716.
     PubMed    
     
     
     September 2020
354. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
     Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
     J Am Coll Cardiol. 2020;76:1501-1502.
     PubMed    
     
     
     
355. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
     Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:1305-1314.
     PubMed     Abstract available
     
     
     
356. GOTTLIEB SS, Ahmed T
     Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
     J Am Coll Cardiol. 2020;76:1049-1050.
     PubMed    
     
     
     
357. GUAZZI M, Ghio S, Adir Y
     Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:1102-1111.
     PubMed     Abstract available
     
     
     
358. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
     Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
     J Am Coll Cardiol. 2020;76:1084-1101.
     PubMed     Abstract available
     
     
     August 2020
359. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
     Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
     J Am Coll Cardiol. 2020;76:930-941.
     PubMed     Abstract available
     
     
     
360. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
     Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
     J Am Coll Cardiol. 2020;76:767-777.
     PubMed     Abstract available
     
     
     
361. COX ZL, Stevenson LW
     The Weight of Evidence for Diuretics and Parachutes.
     J Am Coll Cardiol. 2020;76:680-683.
     PubMed    
     
     
     
362. BAYES-GENIS A, Nunez J, Lupon J
     Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
     J Am Coll Cardiol. 2020;76:515-517.
     PubMed    
     
     
     
363. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
     Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
     J Am Coll Cardiol. 2020;76:503-514.
     PubMed     Abstract available
     
     
     July 2020
364. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
     Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
     J Am Coll Cardiol. 2020;76:405-415.
     PubMed     Abstract available
     
     
     
365. JANUZZI JL JR, Ibrahim NE
     The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
     J Am Coll Cardiol. 2020;76:14-16.
     PubMed    
     
     
     June 2020
366. MEHRA MR, Grazette LP
     Untimely Trial Publication: A Sin of Omission?
     J Am Coll Cardiol. 2020;75:3162-3163.
     PubMed    
     
     
     
367. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
     Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
     J Am Coll Cardiol. 2020;75:3033-3043.
     PubMed     Abstract available
     
     
     
368. PARKER WF, Chung K, Anderson AS, Siegler M, et al
     Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
     J Am Coll Cardiol. 2020;75:2906-2916.
     PubMed     Abstract available
     
     
     
369. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
     Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;75:2851-2862.
     PubMed     Abstract available
     
     
     May 2020
370. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
     Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
     J Am Coll Cardiol. 2020;75:2642-2644.
     PubMed    
     
     
     
371. MEINERTZ T, Munzel T
     Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
     J Am Coll Cardiol. 2020;75:2107-2109.
     PubMed    
     
     
     April 2020
372. REDFORS B, Furer A, Selker HP, Thiele H, et al
     Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
     J Am Coll Cardiol. 2020;75:1743-1754.
     PubMed     Abstract available
     
     
     March 2020
373. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
     Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
     J Am Coll Cardiol. 2020;75:1501-1502.
     PubMed    
     
     
     
374. PALAZZUOLI A, Ruocco G
     Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
     J Am Coll Cardiol. 2020;75:1500-1501.
     PubMed    
     
     
     
375. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
     Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
     J Am Coll Cardiol. 2020;75:1471-1487.
     PubMed     Abstract available
     
     
     
376. NIJST P, Martens P, Dauw J, Tang WHW, et al
     Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
     J Am Coll Cardiol. 2020;75:1426-1438.
     PubMed     Abstract available
     
     
     
377. KITZMAN DW, Upadhya B, Felker GM
     A Biomarker Approach to Understanding HFpEF.
     J Am Coll Cardiol. 2020;75:1296-1298.
     PubMed    
     
     
     
378. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
     Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
     J Am Coll Cardiol. 2020;75:1249-1262.
     PubMed     Abstract available
     
     
     
379. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
     Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
     J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
     PubMed    
     
     
     
380. SABBATINI AR, Kararigas G
     Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;75:1074-1082.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.